Semaglutide, the active ingredient in Ozempic and Wegovy, and tirzepatide, the active ingredient in Mounjaro and Zepbound, have shifted this paradigm
We dont have a definitive answer yet, but heres what we do know: Using GLP-1s for at least 12 months improves outcomes Stopping often leads to weight regain
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
Retatrutide, in his view, represents more than a medication, it signals a future where optimization, physique, and performance are increasingly influenced by biotechnology
The FDA has approved Wegovy, Zepbound, and Saxenda to help with weight loss
The 28-Day Rule Once reconstituted with bacteriostatic water, peptides begin degrading